Navigation Links
New study finds that add-on therapy improves depressive symptoms in bipolar disorder
Date:9/2/2008

Philadelphia, PA, September 2, 2008 Lingering depression is a serious and common problem in bipolar disorder, and does not resolve well with existing treatments. Because individuals with both depression and bipolar disorder experience a glutathione deficiency, an antioxidant that protects cells from toxins, researchers in a new study scheduled for publication in the September 15th issue of Biological Psychiatry sought to evaluate whether N-acetyl cysteine (NAC), an over-the-counter supplement that increases brain glutathione, might help alleviate depressive symptoms.

Dr. Michael Berk and colleagues, in a randomized, double-blind, placebo-controlled trial, evaluated the mood symptoms of individuals with bipolar disorder, half of whom received placebo and half of whom received NAC, as an add-on therapy to their usual treatment. Over the 24 weeks of the study, NAC was well tolerated, and induced a marked and significant improvement in depressive symptoms. Ashley Bush, M.D., Ph.D., the article's corresponding author, further explains: "Glutathione is the brain's primary antioxidant defense, and there is evidence of increased oxidative stress in bipolar disorder. Therefore, we studied the potential benefit of NAC treatment in bipolar disorder and found that it impressively remedied residual depressive symptoms."

John H. Krystal, M.D., Editor of Biological Psychiatry and affiliated with both Yale University School of Medicine and the VA Connecticut Healthcare System, comments: "The preliminary evidence of efficacy of NAC is very interesting. This study might suggest a number of novel approaches to treating depression. In subsequent efforts to replicate this preliminary finding, it will be important to determine how much NAC reaches the brain after oral administration." As noted by both the authors and Dr. Krystal, additional studies will be necessary to further evaluate and replicate these findings. However, as Dr. Berk observes, "Br
'/>"/>

Contact: Jayne Dawkins
ja.dawkins@elsevier.com
215-239-3674
Elsevier
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... The global HCIT outsourcing market is forecast ... $50.4 billion by 2018 from $35 billion in 2013. ... industry are driving the HCIT outsourcing market. These industries ... on core business, reduce operational and maintenance costs, increase ... hiring and training costs), share risk, and quickly implement ...
(Date:10/25/2014)... The Wehrman Collaborative, LLC ... for disabled users by disabled users, has granted ... Mackin Educational Resources of Burnsville, Minnesota, for their ... to the Minnesota Alliance for Patient Safety of ... website. Both organizations have met WeCo’s ...
(Date:10/25/2014)... NC (PRWEB) October 25, 2014 Mesothelioma ... who continued to receive pemetrexed (Alimta), after his combination ... read the full story , just posted on the ... from Uji Tokushukai Medical Center in Japan suggests that ... mesothelioma patients who cannot tolerate higher doses ...
(Date:10/25/2014)... Researchers who discovered antibiotics in farmed and wild ... The use of antibiotics in animals, including ... to the development of antibiotic-resistant bacteria that threaten ... study. Each year in the United States, ... kill about 23,000, according to the Infectious Diseases ...
(Date:10/22/2014)... Pittsburgh, Pennsylvania (PRWEB) October 22, 2014 ... fear and uncertainty among parents and athletes at all ... is working to change the current discussion where two ... there are evidence-based therapies that result in full recoveries ... discussion to one based in fact and research, UPMC ...
Breaking Medicine News(10 mins):Health News:Global HCIT Outsourcing Market to Grow at 7.6% CAGR to 2018 Says a Premium Research Report Available at ReportsnReports.com 2Health News:Global HCIT Outsourcing Market to Grow at 7.6% CAGR to 2018 Says a Premium Research Report Available at ReportsnReports.com 3Health News:Global HCIT Outsourcing Market to Grow at 7.6% CAGR to 2018 Says a Premium Research Report Available at ReportsnReports.com 4Health News:IT-Accessibility Award Granted to Education and Health Care for Section 508/WCAG 2Health News:IT-Accessibility Award Granted to Education and Health Care for Section 508/WCAG 3Health News:New Report Illustrates Extended Mesothelioma Survival with “Maintenance Therapy”, According to Surviving Mesothelioma 2Health News:Researchers Say Antibiotics in Fish a Health Concern 2Health News:University of Pittsburgh Medical Center Launches Initiative to Emphasize Concussions Are Treatable 2Health News:University of Pittsburgh Medical Center Launches Initiative to Emphasize Concussions Are Treatable 3Health News:University of Pittsburgh Medical Center Launches Initiative to Emphasize Concussions Are Treatable 4
... ... ... , ... , ...
... ... Jackson & Coker as President of Permanent Recruitment. , ... Alpharetta, GA (Vocus) March 8, 2010 -- Jackson ... the firm’s Permanent Placement Division., , ,“We are pleased that Tony accepted the offer ...
... ... scheduling software. Hakuna understands that in medical emergencies there is no time to be ... the right nurse, ambulance driver, EMT, or doctor scheduled for each shift. , ... (PRWEB) March 8, 2010 -- Hakuna is ...
... New ingredient makes ... ... Relief announced the launch of a new pain relief formula containing HEPES Ester, a patented, ... and swelling of inflamed muscle and joint tissue. This is good news for an estimated ...
... engineers developed a computer-controlled, motorized hand and arm support that will ... over a wider area than otherwise possible, and with less fatigue. ... "We,ve invented a new device the Active Handrest ... their hands such as surgery, painting, electronics repair or other tasks ...
... A new study has found that one in three ... deciding about treatment options felt they did not fully ... and their risk of recurrence. About one in four ... Published early online in CANCER, a peer-reviewed journal of ...
Cached Medicine News:Health News:Survey Reveals Health Insurance and Access to Care Not So Closely Linked 2Health News:Survey Reveals Health Insurance and Access to Care Not So Closely Linked 3Health News:Survey Reveals Health Insurance and Access to Care Not So Closely Linked 4Health News:Survey Reveals Health Insurance and Access to Care Not So Closely Linked 5Health News:Jackson & Coker Names Tony Stajduhar as President of Permanent Recruitment 2Health News:Jackson & Coker Names Tony Stajduhar as President of Permanent Recruitment 3Health News:Hakuna Medical Staff Scheduling Software 2Health News:Physician's Pain Relief Cream Includes Patented Anti-inflammatory in New Formula 2Health News:Physician's Pain Relief Cream Includes Patented Anti-inflammatory in New Formula 3Health News:A high-tech handrest 2Health News:A high-tech handrest 3Health News:A high-tech handrest 4Health News:A high-tech handrest 5Health News:Improvements needed in genomic test result discussions 2
(Date:10/25/2014)... 24, 2014 Best Practices designed the ... with a forum for sharing insights about the ... a mechanism for creating and sharing solutions through ... findings from the Medical Affairs Consortium survey. ... for the first roundtable of the 2014-2015 Medical ...
(Date:10/22/2014)... SANTA CLARA, Calif. , Oct. 22, 2014 /PRNewswire/ ... today announced the introduction of the cQUB™-1 (cQuest Ultrasound ... cQUB white-label ultrasound systems designed and manufactured by Cephasonics ... brand name and model number. Cephasonics will be showcasing ... 2014 being held this week in Chongqing, ...
(Date:10/22/2014)... 2014 Investor-Edge has initiated coverage ... FOLD ), Progenics Pharmaceuticals Inc. (NASDAQ: ... ), Idera Pharmaceuticals Inc. (NASDAQ: IDRA ), ... these five companies can be accessed at: http://investor-edge.com/register ... NASDAQ Composite ended at 4,419.48, up 2.40%, the Dow ...
Breaking Medicine Technology:Strong Participation in Best Practices' Medical Affairs Consortium Survey 2Cephasonics Launches the cQUB-1, First Product in New Family of cQUB White-Label Ultrasound Systems Targeted at Medical Applications 2Cephasonics Launches the cQUB-1, First Product in New Family of cQUB White-Label Ultrasound Systems Targeted at Medical Applications 3Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 2Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 3Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 4Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 5
... SAN DIEGO, Feb. 16, 2012  Cardium Therapeutics (NYSE Amex: ... completed the previously announced sale of 17,857,143 shares of ... gross proceeds of approximately $5.0 million, before deducting placement ... and accredited investors participating in the offering purchased the ...
... Bionovo, Inc. (OTC Link Platform: BNVI.PK) a pharmaceutical company ... effective treatments for women,s health and cancer, announced today ... February 21, 2012 at 1:30 PM PST to discuss ... 31, 2011. (Logo:  http://photos.prnewswire.com/prnh/20111110/SF04662LOGO ) ...
Cached Medicine Technology:Cardium Announces Closing of $5.0 Million Equity Financing 2Cardium Announces Closing of $5.0 Million Equity Financing 3
... Mini Step™ device components are supplied sterile. , ... System is supplied sterile in 2/3, 5, 7/8, ... configurations and combinations. They are used in conjunction ... the Step™ radially Expandable Sleeve. The 5, 7/8, ...
... contains an internal seal to prevent gas leakage ... of pneumoperitoneum. The 5 mm PLUS system includes ... mm - 12 mm as appropriate and is ... of the trocar to allow insertion of smaller ...
VERSAPORT™ Plus RT Single Use Obturators for use with VERSAPORT™ RT Reusable Cannulae....
... SPRING-GRIP™ single use nonconductive anchoring devices are ... mm and 12 mm sizes for use ... mm, 5 mm-10 mm, 5 mm-11 mm, ... sizes for use with the VERSAPORT™, SURGISPIKE™, ...
Medicine Products: